Skip to main content
SpringerLink
Log in

Postmortem Analysis for Inherited Ion Channelopathies

  • Chapter
Essentials of Autopsy Practice

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Escobedo LG, Zack MM. Comparisons of sudden and nonsudden coronary deaths in the United States. Circulation 1996;93:2033–2036.

    CAS  PubMed  Google Scholar 

  2. Goraya TY, Jacobsen SJ, Kottke TE, et al. Coronary heart disease death and sudden cardiac death. Am J Epidemiol 2003;157:763–770.

    Article  PubMed  Google Scholar 

  3. Zheng ZJ, Croft BJ, Giles WH, et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158–2163.

    CAS  PubMed  Google Scholar 

  4. Fineschi V, Pomara C. A forensic pathological approach to sudden cardiac death. In: Tsokos M, editor. Forensic pathology reviews, vol I. Totowa, NJ: Humana Press, 2004:139–145.

    Google Scholar 

  5. Chugh SS, Jui J, Gunson K, et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004;44:1268–1275.

    PubMed  Google Scholar 

  6. Virmani R, Burke AP, Farb A, et al. Sudden cardiac death. Cardiovasc Pathol 2001;10:211–218.

    CAS  PubMed  Google Scholar 

  7. Mittleman RE. The “negative autopsy.” In: Turillazzi E, editor. La dimensione medico-legale della medicina dello sport. Sports medicine: a forensic approach. Rome: Edizioni Colosseum, 1998:169–194.

    Google Scholar 

  8. Cohle SD, Sampson BA. The negative autopsy: sudden cardiac death or other? Cardiovasc Pathol 2001;10:219–222.

    CAS  PubMed  Google Scholar 

  9. Higuchi R. Simple and rapid preparation of samples for PCR. In: Ehrlich HA, editor. PCR technology: principles and applications for DNA amplification. New York: Stockton Press, 1989:31–38.

    Google Scholar 

  10. Bajanowski T, Rossi L, Biondo B, et al. Prolonged QT interval and sudden infant death — report of two cases. Forensic Sci Int 2001;115:147–153.

    Article  CAS  PubMed  Google Scholar 

  11. Sato Y, Sugie R, Tsuchiya B, et al. Comparison of the DNA extraction methods for polymerase chain reaction amplification from formalin-fixed and paraffin-embedded tissues. Diagn Mol Pathol 2001;10:265–271.

    Article  CAS  PubMed  Google Scholar 

  12. Cao W, Hashibe M, Rao JY, et al. Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev 2003;27:397–404.

    Article  CAS  PubMed  Google Scholar 

  13. Mygind T, Ostergaard L, Birkelund S, et al. Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair. BMC Microbiol 2003;3:19.

    Article  PubMed  Google Scholar 

  14. Konomi N, Lebwohl E, Zhang D. Comparison of DNA and RNA extraction methods for mummified tissues. Mol Cell Probes 2002;16:445–451.

    Article  CAS  PubMed  Google Scholar 

  15. Bonin S, Petrera F, Niccolini B, et al. PCR analysis in archival postmortem tissues. Mol Pathol 2003; 56:184–186.

    CAS  PubMed  Google Scholar 

  16. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958;20:1–18.

    CAS  PubMed  Google Scholar 

  17. Braunwald E, Lambrew CT, Rockoff D, et al. Idiopathic hypertrophic subaortic stenosis. Circulation 1964;30(Suppl IV):3–217.

    PubMed  Google Scholar 

  18. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308–1320.

    PubMed  Google Scholar 

  19. Ommen SR, Nishimura RA. Hypertrophic cardiomyopathy. Curr Probl Cardiol 2004;29:233–291.

    Article  Google Scholar 

  20. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Circulation 1995;92:785–789.

    CAS  PubMed  Google Scholar 

  21. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979;43:1242–1244.

    CAS  PubMed  Google Scholar 

  22. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy. J Am Coll Cardiol 1995;26:1699–1708.

    Article  CAS  PubMed  Google Scholar 

  23. Spirito P, Seidman CE, McKenna WJ, et al. The management of hypertrophic cardiomyopathy. N Engl J Med 1997;336:775–785.

    Article  CAS  PubMed  Google Scholar 

  24. Nishimura RA, Holmes DR. Hypertrophic obstructive cardiomyopathy. N Engl J Med 2004;350: 1320–1327.

    Article  CAS  PubMed  Google Scholar 

  25. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy predicts the risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:1778–1785.

    Article  CAS  PubMed  Google Scholar 

  26. Boriani G, Maron BJ, Shen WK, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation 2004;110:e38–42.

    Google Scholar 

  27. Louie EK, Maron BJ. Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness. J Am Coll Cardiol 1986;8:57–65.

    CAS  PubMed  Google Scholar 

  28. Elliott PM, Gimeno Blanes JR, Mahon NG, et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357:420–424.

    CAS  PubMed  Google Scholar 

  29. Maron BJ, Roberts WC. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation 1979;59:689–706.

    CAS  PubMed  Google Scholar 

  30. Ferrans VJ, Morrow AG, Roberts WC. Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. Circulation 1972;45:769–792.

    CAS  PubMed  Google Scholar 

  31. St. John Sutton MG, Lie JT, Anderson KR, et al. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Br Heart J 1980;44:433–443.

    CAS  PubMed  Google Scholar 

  32. Varnava AM, Elliott PM, Mahon N, et al. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001;88:275–279.

    Article  CAS  PubMed  Google Scholar 

  33. Maron BJ, Anan TJ, Roberts WC. Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy. Circulation 1981;63:882–894.

    CAS  PubMed  Google Scholar 

  34. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979;43:1086–1102.

    CAS  PubMed  Google Scholar 

  35. Basso C, Thiene G, Corrado D, et al. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 2000;31:988–998.

    Article  CAS  PubMed  Google Scholar 

  36. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy — pathology and pathogenesis. Histopathology 1995;26:493–500.

    CAS  PubMed  Google Scholar 

  37. Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology 2004;44:412–427.

    Article  CAS  PubMed  Google Scholar 

  38. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212–2218.

    Article  CAS  PubMed  Google Scholar 

  39. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000;102:858–864.

    CAS  PubMed  Google Scholar 

  40. McKenna WJ, England D, Doi YL, et al. Arrhythmia in hypertrophic cardiomyopathy. Br Heart J 1981;46:168–172.

    CAS  PubMed  Google Scholar 

  41. Watkins H. Sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342:422–424.

    Article  CAS  PubMed  Google Scholar 

  42. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342:365–373.

    Article  CAS  PubMed  Google Scholar 

  43. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001;104:557–567.

    Article  CAS  PubMed  Google Scholar 

  44. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta-cardiac myosin heavy chain gene missense mutation. Cell 1990;62: 999–1006.

    CAS  PubMed  Google Scholar 

  45. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058–1064.

    Article  CAS  PubMed  Google Scholar 

  46. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108–1114.

    CAS  PubMed  Google Scholar 

  47. Marian AJ. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000;355:58–60.

    Article  CAS  PubMed  Google Scholar 

  48. Moolman JC, Corfield VA, Posen B, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997;29:549–555.

    CAS  PubMed  Google Scholar 

  49. Enjuto M, Francino A, Navarro-Lopez F, et al. Malignant hypertrophic cardiomyopathy caused by Arg723Gly mutation in beta-myosin heavy chain gene. J Mol Cell Cardiol 2000;32:2307–2313.

    Article  CAS  PubMed  Google Scholar 

  50. Tesson F, Richard P, Charron P, et al. Genotype-phenotype analysis in four families with mutations in the beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy. Hum Mutat 1998;12:385–392.

    Article  CAS  PubMed  Google Scholar 

  51. Spicer RL, Rocchini AP, Crowley DC, et al. Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. Am J Cardiol 1984;53:1614–1619.

    CAS  PubMed  Google Scholar 

  52. Gilligan DM, Chan WL, Joshi J, et al. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;21:1672–1679.

    CAS  PubMed  Google Scholar 

  53. Lakkis NM, Nagueh SF, Dunn JK, et al. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol 2000;36:852–855.

    Article  CAS  PubMed  Google Scholar 

  54. Qin JX, Shiota T, Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001;38:1994–2000.

    CAS  PubMed  Google Scholar 

  55. Gallo P, d’Amati G., Cardiomyopathies. In: Silver MD, Gotlieb AI, Schoen FJ, editors. Cardiovascular pathology. Philadelphia: Churchill Livingstone, 2001:285–325.

    Google Scholar 

  56. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 2000;83:588–595.

    Article  CAS  PubMed  Google Scholar 

  57. Fontaine G, Fontaliran F, Hebert JL, et al. Arrhythmogenic right ventricular dysplasia. Annu Rev Med 1999;50:17–35.

    Article  CAS  PubMed  Google Scholar 

  58. Thiene G, Basso C. Arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc Pathol 2001;10:109–117.

    Article  CAS  PubMed  Google Scholar 

  59. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129–133.

    CAS  PubMed  Google Scholar 

  60. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000;36:2226–2233.

    Article  CAS  PubMed  Google Scholar 

  61. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997; 30:1512–1520.

    Article  CAS  PubMed  Google Scholar 

  62. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Br Heart J 1994;71:215–218.

    CAS  PubMed  Google Scholar 

  63. Obata H, Mitsuoka T, Kikuchi Y, et al. Twenty-seven-year follow-up of arrhythmogenic right ventricular dysplasia. Pacing Clin Electrophysiol 2001;24:510–511.

    Article  CAS  PubMed  Google Scholar 

  64. Dalla Volta S, Battaglia G, Zerbini E. “Auricularization” of right ventricular pressure curve. Am Heart J 1961;61:25–33.

    Google Scholar 

  65. Fontaine G, Guiraudon G, Frank R, et al. Stimulation studies and epicardial mapping in ventricular tachycardia: study of mechanisms and selection for surgery. In: Kulbertus HE, editor. Reentrant arrhythmias: mechanisms and treatment. Lancaster: MTP Press Limited, 1977:334–350.

    Google Scholar 

  66. Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation 2000;101:E101–E106.

    CAS  PubMed  Google Scholar 

  67. Basso C, Thiene G, Corrado D, et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 1996;94:983–991.

    CAS  PubMed  Google Scholar 

  68. Midiri M, Finazzo M, Brancato M, et al. Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol 1997;7:307–312.

    Article  CAS  PubMed  Google Scholar 

  69. Tandri H, Calkins H, Nasir K, et al. Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2003;14:476–482.

    Article  PubMed  Google Scholar 

  70. Danieli GA, Rampazzo A. Genetics of arrhythmogenic right ventricular cardiomyopathy. Curr Opin Cardiol 2002;17:218–221.

    Article  PubMed  Google Scholar 

  71. Rampazzo A, Nava A, Danieli GA, et al. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23–q24. Hum Mol Genet 1994;3:959–962.

    CAS  PubMed  Google Scholar 

  72. Ahmad F, Li D, Karibe A, et al. Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. Circulation 1998;98:2791–2795.

    CAS  PubMed  Google Scholar 

  73. Li D, Ahmad F, Gardner MJ, et al. The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12–p14. Am J Hum Genet 2000;66:148–156.

    Article  CAS  PubMed  Google Scholar 

  74. Melberg A, Oldfors A, Blomstrom-Lundqvist C, et al. Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 1999;46:684–692.

    Article  CAS  Google Scholar 

  75. Protonotarios N, Tsatsopoulou A, Patsourakos P, et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986;56:321–326.

    CAS  PubMed  Google Scholar 

  76. Norgett EE, Hatsell SJ, Carvajal-Huerta L, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000;9:2761–2766.

    Article  CAS  PubMed  Google Scholar 

  77. Link MS, Wang PJ, Haugh CJ, et al. Arrhythmogenic right ventricular dysplasia: clinical results with implantable cardioverter defibrillators. J Interv Card Electrophysiol 1997;1:41–48.

    CAS  PubMed  Google Scholar 

  78. Fontaine G, Tonet J, Gallais Y, et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep 2000;2:498–506.

    CAS  PubMed  Google Scholar 

  79. Maron BJ. Right ventricular cardiomyopathy: another cause of sudden death in the young. N Engl J Med 1988;318:178–180.

    CAS  PubMed  Google Scholar 

  80. Gallo P, d’Amati G. Cardiomyopathies. In: Silver MD, Gotlieb AI, Schoen FJ, editors: Cardiovascular pathology. Philadelphia: Churchill Livingstone, 2001:308–309.

    Google Scholar 

  81. Michalodimitrakis EN, Tsiftsis DDA, Tsatsakis AM, et al. Sudden cardiac death and right ventricular dysplasia. Am J Forensic Med Pathol 2001;22:19–22.

    Article  CAS  PubMed  Google Scholar 

  82. Wehrens XH, Vos MA, Doevendans PA, et al. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002;137:981–992.

    CAS  PubMed  Google Scholar 

  83. Vincent GM. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med 1998;49:263–274.

    CAS  PubMed  Google Scholar 

  84. Zeltser D, Justo D, Halkin A, et al. Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine 2003;82:282–290.

    Article  PubMed  Google Scholar 

  85. Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA 2003;289:2120–2127.

    Article  PubMed  Google Scholar 

  86. Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002;105:1943–1948.

    Article  CAS  PubMed  Google Scholar 

  87. Roden DM. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res 2001;50:24–231.

    Article  Google Scholar 

  88. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89–95.

    CAS  PubMed  Google Scholar 

  89. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: a prospective international study. Circulation 1985;71:17–21.

    CAS  PubMed  Google Scholar 

  90. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991;84:1136–1144.

    CAS  PubMed  Google Scholar 

  91. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960–965.

    Article  CAS  PubMed  Google Scholar 

  92. Locati EH, Zareba W, Moss AJ, et al. Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome. Circulation 1998;97:2237–2244.

    CAS  PubMed  Google Scholar 

  93. Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999;84:876–879.

    Article  CAS  PubMed  Google Scholar 

  94. Ali RH, Zareba W, Moss AJ, et al. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol 2000;85:457–461.

    Article  CAS  PubMed  Google Scholar 

  95. Wilde AA, Jongbloed RJ, Doevendans PA, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol 1999;33:327–332.

    Article  CAS  PubMed  Google Scholar 

  96. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999;99:529–533.

    CAS  PubMed  Google Scholar 

  97. Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999;34:823–829.

    CAS  PubMed  Google Scholar 

  98. Swan H, Toivonen L, Viitasalo M. Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. Eur Heart J 1998;19:508–513.

    CAS  PubMed  Google Scholar 

  99. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between the sudden infant death syndrome and the long-QT syndrome. N Engl J Med 2000;343:262–267.

    CAS  PubMed  Google Scholar 

  100. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 2001;286:2264–2269.

    Article  CAS  PubMed  Google Scholar 

  101. Keating M, Atkinson D, Dunn C, et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991;252:704–706.

    CAS  PubMed  Google Scholar 

  102. Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994;8:141–147.

    Article  CAS  PubMed  Google Scholar 

  103. Abbott GW, Sesti F, Splawski I, et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999;97:175–187.

    Article  CAS  PubMed  Google Scholar 

  104. Wang Q, Li Z, Shen J, et al. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9–16.

    Article  CAS  PubMed  Google Scholar 

  105. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia sudden cardiac death. Nature 2003;421:634–639.

    Article  CAS  PubMed  Google Scholar 

  106. Fodstad H, Swan H, Auberson M, et al. Loss-of-function mutations of the K(+) channel gene KCNJ2 constitute a rare cause of long QT syndrome. J Mol Cell Cardiol 2004;37:593–602.

    Article  CAS  PubMed  Google Scholar 

  107. Chen Q, Zhang D, Gingell RL, et al. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation 1999;99:1344–1347.

    CAS  PubMed  Google Scholar 

  108. Splawski I, Timothy KW, Vincent GM, et al. Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med 1997;336:1562–1567.

    Article  CAS  PubMed  Google Scholar 

  109. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death. Am Heart J 1957;54:59–68.

    Article  CAS  PubMed  Google Scholar 

  110. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000;36:1–12.

    Article  CAS  PubMed  Google Scholar 

  111. Groh WJ, Silka MJ, Oliver RP, et al. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 1996;78:703–706.

    Article  CAS  PubMed  Google Scholar 

  112. Dorostkar PC, Eldar M, Belhassen B, et al. Long-term follow-up of patients with long-QT syndrome treated with beta-blockers and continuous pacing. Circulation 1999;100:2431–2436.

    CAS  PubMed  Google Scholar 

  113. Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: a decade of progress. Circ Res 2002;91:1114–1118.

    Article  CAS  PubMed  Google Scholar 

  114. Gussak I, Antzelevitch C, Bjerregaard P, et al. The Brugada syndrome: clinical, electrophysiologic, and genetic aspects. J Am Coll Cardiol 1999;33:5–15.

    Article  CAS  PubMed  Google Scholar 

  115. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268–272.

    Article  CAS  PubMed  Google Scholar 

  116. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595–2600.

    CAS  PubMed  Google Scholar 

  117. Wilde AAM, Antzelevitch C, Borggrefe M, et al. The Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514–2519.

    Article  PubMed  Google Scholar 

  118. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342–1347.

    Article  PubMed  Google Scholar 

  119. Alings M and Wilde A. “Brugada” syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666–673.

    CAS  PubMed  Google Scholar 

  120. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391–1396.

    CAS  PubMed  Google Scholar 

  121. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73–78.

    Article  PubMed  Google Scholar 

  122. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3. Circulation 1998;97:457–460.

    CAS  PubMed  Google Scholar 

  123. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome. Circulation 2000;102:2509–2515.

    CAS  PubMed  Google Scholar 

  124. Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40:350–356.

    Article  CAS  PubMed  Google Scholar 

  125. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101:510–515.

    CAS  PubMed  Google Scholar 

  126. Priori SG, Napolitano C, Schwartz PJ, et al. The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. Circulation 2000;102:945–947.

    CAS  PubMed  Google Scholar 

  127. Junttila MJ, Raatikainen MJ, Karjalainen J, et al. Prevalence and prognosis of subjects with Brugadatype ECG pattern in a young and middle-aged Finnish population. Eur Heart J 2004;25:847–848.

    Article  Google Scholar 

  128. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092–3096.

    Article  PubMed  Google Scholar 

  129. Brugada P, Brugada R, Mont L, et al. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 2003;14:455–457.

    Article  PubMed  Google Scholar 

  130. Kanda M, Shimizu W, Matsuo K, et al. Electrophysiologic characteristics and implications of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 2002;39:1799–1805.

    Article  PubMed  Google Scholar 

  131. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293–296.

    CAS  PubMed  Google Scholar 

  132. Balser JR. The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 2001;33:599–613.

    Article  CAS  PubMed  Google Scholar 

  133. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002;40:330–334.

    Article  PubMed  Google Scholar 

  134. Glatter KA, Wang Q, Keating M, et al. Effectiveness of sotalol treatment in symptomatic Brugada syndrome. Am J Cardiol 2004;93:1320–1322.

    Article  CAS  PubMed  Google Scholar 

  135. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999;100:1660–1666.

    CAS  PubMed  Google Scholar 

  136. Clancy CE, Rudy Y. Na+ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 2002;105:1208–1213.

    Article  PubMed  Google Scholar 

  137. Kakishita M, Kurita T, Matsuo K, et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646–1653.

    Article  CAS  PubMed  Google Scholar 

  138. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485–490.

    CAS  PubMed  Google Scholar 

  139. Swan H, Piippo K, Viitasalo M, et al. Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999;34:2035–2042.

    CAS  PubMed  Google Scholar 

  140. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69–74.

    Article  CAS  PubMed  Google Scholar 

  141. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196–200.

    CAS  PubMed  Google Scholar 

  142. Leenhardt A, Lucet V, Denjoy I, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512–1519.

    CAS  PubMed  Google Scholar 

  143. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine-or exercise-induced polymorphic ventricular tachycardia. Circulation 2001;103:2822–2827.

    CAS  PubMed  Google Scholar 

  144. Fisher JD, Krikler D, Hallidie-Smith KA. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol 1999;34:2015–2022.

    Article  CAS  PubMed  Google Scholar 

  145. Tunwell RE, Wickenden C, Bertrand BM, et al. The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis. Biochem J 1996;318:477–487.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Sacramento, CA, USA

    Kathryn A. Glatter MD (Assistant Professor of Medicine) & Yuxia He MD (Postgraduate Researcher)

  2. Department of Internal Medicine, Division of Cardiovascular Medicine, University of California, Davis, CA, USA

    Nipavan Chiamvimonvat MD (Assistant Professor of Medicine)

  3. Department of Cardiology and Intensive Care, Hopital Louis Pradel, Lyon, France

    Philippe Chevalier MD, PhD (Chief of Electrophysiology)

  4. Department of Forensic Pathology, University of Foggia, Foggia, Italy

    Emanuela Turillazzi MD, PhD (Assistant Professor of Forensic Pathology)

Authors
  1. Kathryn A. Glatter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nipavan Chiamvimonvat MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuxia He MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philippe Chevalier MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emanuela Turillazzi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Leicester, Leicester, UK

    Guy N. Rutty MD, MBBS, FRCPath, DipRCPath(Forensic) (Consultant Home Office Pathologist) (Consultant Home Office Pathologist)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Glatter, K.A., Chiamvimonvat, N., He, Y., Chevalier, P., Turillazzi, E. (2006). Postmortem Analysis for Inherited Ion Channelopathies. In: Rutty, G.N. (eds) Essentials of Autopsy Practice. Springer, London. https://doi.org/10.1007/1-84628-026-5_2

Download citation

  • DOI: https://doi.org/10.1007/1-84628-026-5_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-967-8

  • Online ISBN: 978-1-84628-026-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation